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Abstract
I In nt tr ro od du uc ct ti io on n: :   Syncope is a common presentation of sinus node dysfunction (SND).
Some patients who receive a permanent pacemaker due to SND do not benefit
from it and further diagnostic workup leads to the diagnosis of vasovagal syn-
cope (VVS). The aim of the study was to identify electrophysiological criteria that
can be used for identification of patients with SND and concurrent VVS.
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: :   Transoesophageal atrial pacing (TAP) was performed in
100 patients divided into four groups depending on symptoms and TAP results.
Standard electrophysiological parameters of sinus node function and their vari-
ability were obtained in the basal state and after pharmacological autonomic
blockade (AB).
R Re es su ul lt ts s: :   Patients with concurrent SND and VVS had a greater variability of sinoa-
trial conduction time assessed by Strauss’ method than patients without incidents
of syncope (83.2 ±53.9 vs. 34.1 ±19.6, 47.8 ±33.6 and 32.1 ±22.99). Apart from abnor-
mal sinus node recovery time and second pause, patients with SND had bigger
basal state variability of these parameters. In patients with SND and concurrent
vasovagal syncope the variability of sinus node recovery time (SNRT), corrected
SNRT (cSNRT) and second pause (IIP) decreased after autonomic blockade.
C Co on nc cl lu us si io on ns s: :   Patients with concurrent SND and VVS have distinct electrophys-
iological features – greater sinoatrial conduction time (SACT) variability and the
decrease of SNRT, cSNRT and IIP variability after AB. However, further studies
in larger study groups are needed to validate our findings. Transoesophageal
atrial pacing is a useful procedure in patients with syncope, especially when
the coexistence of more than one cardiac cause is suspected. 
K Ke ey y   w wo or rd ds s: :   syncope, sinus node dysfunction, vasovagal syncope, transoesophageal
atrial pacing, sinoatrial conduction time variability.
Introduction
Syncope is a common presentation of sinus node dysfunction. Howev-
er, there are no exact values of electrophysiological parameters which can
be useful to discriminate whether sinus node dysfunction is the cause of
syncope. The sensitivity of sinus node recovery time (SNRT) or corrected
C Co or rr re es sp po on nd di in ng g   a au ut th ho or r: :   
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SNRT (cSNRT) is limited, although marked prolon-
gation of SNRT/cSNRT increases the possibility that
sinus node dysfunction may be responsible for syn-
cope [1]. Sinoatrial conduction time (SACT) assess-
ment is not recognized as a diagnostic tool for syn-
cope [2]. It is known that some patients who receive
permanent pacemakers due to sinus node dys-
function (SND) do not benefit from it and have syn-
cope recurrences [3]. In some such cases further
diagnostic workup leads to the diagnosis of vaso-
vagal syncope (VVS). On the other hand, the only
commonly used test for diagnosing vasovagal syn-
cope, the head-up tilt test (HUTT), has many limi-
tations [4]. Moreover, the mechanism of syncope in
patients without organic heart disease does not
correlate with findings during HUTT [5, 6].
The aim of the present study was to identify
electrophysiological criteria that can be used to
identify patients with sinus node dysfunction and
concurrent vasovagal syncope. 
Material and methods
P Pa at ti ie en nt ts s
Transoesophageal atrial pacing (TAP) was per-
formed in 100 patients. The study group was divid-
ed into four groups depending on symptoms and
results of TAP:
• group 1: patients with SND and a history sug-
gesting VVS,
• group 2: patients with SND with no previous syn-
cope,
• group 3: patients without SND but with a history
suggesting VVS,
• group 4: patients without SND and without a his-
tory suggesting VVS.
We used the following diagnostic criteria for
sinus node dysfunction:
• clinical features: syncope or presyncope, dizziness,
shortness of breath, fatigue, blurred vision, mem-
ory loss, chest pain, palpitations [7],
• electrocardiographic features: sinus brady  cardia
<  50/min,  sinus  pause  >  2  s,  sinoatrial  exit 
block [7],
• electrophysiological criteria: corrected sinus node
recovery time (cSNRT) > 525 ms and/or sinoatri-
al conduction time by Strauss’ method (SACT St)
> 200 ms and/or intrinsic heart rate (IHR) lower
than predicted [8, 9].
The following history findings suggested vaso-
vagal syncope [2]:
• triggers of syncope: prolonged standing, warm
environment, injections, sight of blood or syringes,
pain, stressful situations,
• concurrent symptoms: diaphoresis, dyspnoea,
• short duration of syncope episodes,
• incidence characteristic: occurrence of different
types of syncope suggesting more than one cause
of incidents.
Inclusion criteria:
• diagnostic TAP in patients with or without a his-
tory of syncope,
• age over 18 years.
Exclusion criteria:
• inability to safely discontinue medications which
could affect electrophysiological properties of the
heart, for at least 5 half-lives prior to TAP (at least
3 months in case of amiodarone),
• contraindications to drugs used in the TAP pro-
tocol,
• heart rhythm other than sinus rhythm at the
beginning of TAP and HUTT.
The patients had no symptoms of heart, renal,
respiratory or hepatic failure. Patients with com-
plex ventricular arrhythmias were not included in
the study. The prevalence of coronary artery dis-
ease, hypertension and diabetes as well as inci-
dence of syncope and palpitations are shown in
Table I. In group 4 there were 3 patients with
a history of a single syncope due to an overdose
of antihypertensive drugs. They all had a nega-
tive HUTT.
P Pa ar ra am me et te er r G Gr ro ou up p   1 1 G Gr ro ou up p   2 2 G Gr ro ou up p   3 3 G Gr ro ou up p   4 4
Number of patients 16 24 32 28
Age [years]:
Mean 45.9 63.8 43.3 52.1
Standard deviation 21.0 15.9 18.6 18.6
Median (min-max) 49 (18-84) 67.5 (26-90) 44.5 (18-76) 49.5 (18-90)
Gender: females/males 10/6 18/6 23/9 18/10
Coronary artery disease, n (%) 2 (12.5%) 1 (4.2%) 5 (15.6%) 2 (7.1%)
Hypertension, n (%) 2 (12.5%) 1 (4.2%) 4 (12.5%) 5 (17.9%)
Diabetes, n (%) 0 (0%) 0 (0%) 1 (3.1%) 1 (3.6%)
Syncope, n (%) 16 (100%) 0 (0%) 32 (100%) 3 (10.1%)
Palpitations as chief complaint, n (%)  2 (12.5%) 4 (16.7%) 14 (43.8%) 18 (64.3%)
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S St tu ud dy y   p pr ro ot to oc co ol l
The study complies with the Declaration of
Helsinki; the protocol of the study was approved by
the locally appointed ethics committee. Informed
consent was obtained from each patient.
Head-up tilt test was performed in all patients
with previous syncope [10]. The test was performed
between 8 and 11 am, after an overnight fast. The
patient remained supine for 20 min and then the
table was tilted to 60°. An active test with 400 ﾵg
of nitroglycerine (aerosol, sublingually) was then
performed. Passive test lasted 30 min; active test
lasted 20 min, or until syncope occurred. In case
of contraindications to NTG, a 45 min passive test
was  performed.  The  results  were  interpreted
according to 2009 ESC guidelines on management
of syncope [2]. 
Transoesophageal electrophysiological testing
was performed in 100 patients [11, 12]. The combi-
nation of midazolam and fentanyl was administered
to alleviate discomfort related to stimulation. This
combination of drugs is safe and does not affect
the sinus node function, atrioventricular conduc-
tion or the inducibility of tachycardia [13-15].
EDP-1 type 8-point electrodes and a program-
mable stimulator SP-5 plus (OBREAM – Zabrze,
Poland) were used. The Fisher-Bloom EP System
and Easy View Plus software (Prosmed, Poland) for
personal computer were used for recordings. Puls-
es of 5 ms width and amplitude up to 20 mA were
delivered. We obtained: SNRT, cSNRT, second pause
(IIP), sinoatrial conduction time assessed by Strauss’
(SACT St) and Narula’s (SACT N) methods and the
Wenckebach point (WP). 
All the parameters were also assessed after
pharmacological autonomic blockade (AB) with pro-
pranolol (0.1 mg/kg) and atropine (0.02 mg/kg)
administered slowly intravenously following the pro-
tocol by Wallin [16]. The above protocol is consid-
ered safe and efficient in producing a complete
autonomic blockade.
Intrinsic heart rate (IHR) was the heart rate
recorded after the pharmacological autonomic den-
ervation. Predicted IHR (IHRp) is age-appropriate
IHR which is obtained using the formula: IHRp =
118.1 ￗ (0.57 – age [years]) [17]. An abnormal value
of IHR was defined when it was lower than age pre-
dicted by more than 10%.
Sinoatrial conduction time was evaluated by
Narula’s method using 8 impulses with the rate
slightly faster than the basic cycle length (BCL +
10/min) and repeated 3 times [18]. Sinoatrial con-
duction  time  was  also  assessed  by  the  atrial
extrastimulus technique [19]. Every eighth sinus
cycle (A1 – A1) an extrastimulus (A2) was delivered
and the return cycle (A2 – A3) was measured. We
used 10 ms decrements until reaching atrial refrac-
toriness. To obtain SACT by Strauss’ method the
response of sinus node in so-called Zone II [(A1-A3)
< 2(A1-A1)] was considered and the measurements
from 1/3 external part of zone II were used.
Sinoatrial conduction time was estimated using
the formula: SACT St = 1/2 [ (A2 – A3) – (A1 – A1)].
Sinoatrial conduction time variability was assessed
using the following methods:
method (1): SACT max – SACT min,
method (2): (SACT max – SACT min)/SACT max,
(SACT max and SACT min are maximal and min-
imal values of SACT).
For SNRT, cSNRT and IIP the variability was
defined as the difference between maximal and
minimal values of the above parameters.
S St ta at ti is st ti ic ca al l   a an na al ly ys si is s
Data are presented as mean ± SD or percentage
as appropriate. Comparison within a group was per-
formed with Student’s t test or Mann-Whitney
U test. Comparisons between groups were per-
formed by analysis of variance and post-hoc tests.
Statistical significance was established at a value
of p < 0.05. All analyses were performed using 
STATISTICA, version 7.1 (StatSoft, Inc).
Results
H He ea ad d- -u up p   t ti il lt t   t te es st t
Group 1: HUTT was positive in 75% of patients
(in 12 out of 16 pts), the pattern being mixed (VASIS
type 1) in 8 (66.7%), cardioinhibitory (VASIS type 2)
in 3 (25%), and vasodepressor (VASIS type 3) in 1
(8.3%).
Group 3: HUTT was positive in 65.6% of patients
(in 21 out of 32 pts), the pattern being mixed (VASIS
type 1) in 14 (66.7%), cardioinhibitory (VASIS type
2) in 4 (19%), and vasodepressor (VASIS type 3) in
3 (14.3%) patients.
T Tr ra an ns so oe es so op ph ha ag ge ea al l   a at tr ri ia al l   p pa ac ci in ng g
Transoesophageal atrial pacing was performed
in 100 patients. There were no complications. Sinus
node recovery time, cSNRT and IIP were success-
fully obtained in all patients. Sinoatrial conduction
time assessed by Narula’s method in the basal state
was acquired in all patients but it was impossible
to  assess  SACT  N  after  AB  in  6%  of  patients
because of the irregularity of sinus rhythm (in 2 sub-
jects), single premature ventricular or supraventric-
ular beats (3 subjects) and the onset of atrial fib-
rillation  before  the  completion  of  the  study 
(1 subject). Sinoatrial conduction time assessed by
Strauss’ in the basal state was obtained in 89% and
after AB in 87% of patients. Reasons for missing
data were lack of so-called Zone II in 4 patients,
numerous supraventricular beats in 6 patients, runs966 Arch Med Sci 6, December / 2011
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of AV junctional rhythm in 2 patients and temporary
malfunction of the recording device in two subjects.
S St ta an nd da ar rd d   p pa ar ra am me et te er rs s
The values of SNRT, cSNRT, IIP, SACT N and SACT
St are shown in Table II. After AB, patients in group 1
had significantly shorter SNRT, cSNRT and IIP com-
pared to patients in group 2, while there were no
significant differences between patients in groups
1 and 2 concerning SNRT and cSNRT in the basal
state. Patients in group 1 also had shorter SACT N
and SACT St but the difference was significant only
with regard to SACT N. Mean cSNRT, SACT N and
SACT St values in group 1 patients shortened after
AB and were not significantly different than in
groups without SND (3 and 4). All significant dif-
ferences and the respective p-values are shown in
Table II. 
I In nt tr ri in ns si ic c   h he ea ar rt t   r ra at te e
The values of intrinsic heart rate were 80 ±11, 
70 ±11, 91 ±12 and 90 ±15/min in groups 1 to 4,
respectively. Intrinsic heart rate values were signif-
icantly different in group 1 compared to all the oth-
er groups (group 1 vs. 2: p = 0.016; 1 vs. 3: p = 0.003;
1 vs. 4: p = 0.020). Abnormal values of IHR were
found in 50% of patients in group 1 and 54% in
group 2. 
S Si in no oa at tr ri ia al l   c co on nd du uc ct ti io on n   t ti im me e   v va ar ri ia ab bi il li it ty y
In patients with SND and VVS (group 1) SACT St
variability was significantly different compared to
other groups (Table III). After AB the differences dis-
appeared with the exception of SACT St variability
as determined by method (2): (SACT max – SACT
min)/SACT max (comparing groups 1 and 2). For
method (1): SACT max – SACT min, there was an
insignificant trend for greater SACT St variability in
group 1 (p = 0.068).
The SACT N variability in patients in group 1 was
not different from SACT N variability in patients in
other groups. Groups with positive (A) or negative
(B) responses to HUTT (3A vs. 3B and 1A + 3A vs. 1B
+ 3B) did not differ with regard to SACT variability.
S SN NR RT T, ,   c cS SN NR RT T   a an nd d   I II IP P   v va ar ri ia ab bi il li it ty y
In the basal state, the SNRT, cSNRT and IIP vari-
ability in patients in group 1 was not different com-
pared to group 2, but there was a significant dif-
ference between group 1 patients and patients
without SND (group 3 as well as group 4). After AB,
the variability of SNRT and cSNRT in group 1 was
similar to groups 3 and 4 and significantly different
only from group 2. Patients in group 1 had signifi-
cantly different IIP variability compared to all oth-
er patients (Figures 1-3).
W We en nc ck ke eb ba ac ch h   p po oi in nt t
In the basal state the values of Wenckebach
point were 134 ±42, 163 ±33, 156 ±27 and 174
±28/min in groups 1 to 4, respectively. After auto-
nomic blockade they were 148 ±31, 165 ±26, 166 ±21
and 175 ±26/min in groups 1 to 4, respectively.
Patients in group 1 had a lower WP than patients
in  group  4  (p =  0.003  in  the  basal  state  and 
p = 0.004 after AB). There were no statistically sig-
nificant differences between group 1 and 2 or 3.
After correction for age, abnormal WP was found
in 6 (37.5%), 3 (12.5%), 9 (28 %) and 1 (3.6%) patient
S Si in nu us s   n no od de e    G Gr ro ou up p   1 1 G Gr ro ou up p   2 2 G Gr ro ou up p   3 3 G Gr ro ou up p   4 4 G Gr ro ou up p   1 1   v vs s. .   2 2 G Gr ro ou up p   1 1   v vs s. .   3 3 G Gr ro ou up p   1 1   v vs s. .   4 4
p pa ar ra am me et te er rs s   [ [m ms s] ] V Va al lu ue e   o of f   p p V Va al lu ue e   o of f   p p V Va al lu ue e   o of f   p p
B Ba as sa al l   s st ta at te e
SNRT  1579 ±578 1652 ±310 1151 ±213 1178 ±242 NS 0.0001 0.0011
cSNRT 613 ±412 641 ±204 355 ±95 345 ±101 NS < 0.0001 0.0002
IIP 1363 ±321 1421 ±288 927 ±279 1009 ±285 NS < 0.0001 0.0005
SACT N 259 ±87 236 ±63 208 ±63 191 ±36 NS 0.0171 0.0101
SACT St 193 ±42 187 ±53 163 ±35 166 ±30 NS 0.0212 0.0456
A Au ut to on no om mi ic c   b bl lo oc ck ka ad de e
SNRT 1217 ±354 2185 ±957 953 ±168 948 ±197 < 0.0001 0.0069 0.0090
cSNRT 417 ±261 1202 ±890 276 ±84 267 ±84 < 0.0001 NS NS
IIP 1002 ±295 1748 ±913 744 ±133 768 ±199 0.0002 0.0019 0.0090
SACT N 153 ±67 222 ±115 126 ±29 122 ±44 0.0180 NS NS
SACT St 130 ±49 179 ±65 118 ±23 121 ±23 NS NS NS
T Ta ab bl le e   I II I. .   Values of SNRT, cSNRT, IIP, SACT N and SACT St and comparison of standard parameters in groups 1-4
SNRT – sinus node recovery time, cSNRT – corrected sinus node recovery time, IIP – second pause, SACT N – sinoatrial conduction time by Naru-
la’s method, SACT St – sinoatrial conduction time by Strauss’ method, NS – non-significantArch Med Sci 6, December / 2011 967
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in groups 1 to 4, respectively. Autonomic blockade
decreased the number of patients with abnormal
WP, especially in patients with VVS. After AB,
Wenckebach point below the normal range was
found in 5 (31.3%), 1 (4.2%), 2 (6.3%) and 1 (3.6%)
patient in groups 1 to 4, respectively.
Discussion
In 1972 Mandel et al. described sinus node recov-
ery time as a new method of assessing sinus node
function [20]. After many years the prognostic val-
ue of SNRT is still not well defined. Menozzi et al.
presented a prospective study in which patients
M Me et th ho od d B Ba as sa al l    A Au ut to on no om mi ic c    B Ba as sa al l    A Au ut to on no om mi ic c    B Ba as sa al l    A Au ut to on no om mi ic c   
s st ta at te e b bl lo oc ck ka ad de e s st ta at te e b bl lo oc ck ka ad de e s st ta at te e b bl lo oc ck ka ad de e
G Gr ro ou up p   1 1   v vs s. .   2 2 G Gr ro ou up p   1 1   v vs s. .   3 3 G Gr ro ou up p   1 1   v vs s. .   4 4
1 1 2 2 1 1 2 2 1 1 3 3 1 1 3 3 1 1 4 4 1 1 4 4
1 83.2  35.1  83.2  47.8  83.2  32.1
±53.9 ±19.6 ±53.9 ±33.6 ±53.9 ±22.99
p = 0.004 p = 0.0291 p = 0.0009
2 0.42  0.20  0.10  0.07  0.42  0.28  0.42  0.19 
±0.22 ±0.10 ±0.10 ±0.04 ±0.22 ±0.16 ±0.22 ±0.11
p = 0.0031 p = 0.0017 p = 0.0391 p = 0.0017
T Ta ab bl le e   I II II I. .   Sinoatrial conduction time by Strauss’ method (SACT St ) variability in groups 1-4
Method (1): SACT max – SACT min, method (2): (SACT max – SACT min)/SACT max, group 1: SND(+) VVS(+), group 2: SND(+), group 3: VVS (+),
group 4: SND(–) VVS (–), NS – non-significant
NS
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F Fi ig gu ur re e   1 1. .   Sinus node recovery time (SNRT) variability in groups 1-4 in the basal state (A A) and after autonomic block-
ade (B B)
Group 1: SND(+) VVS(+), group 2: SND(+), group 3: VVS (+), group 4: SND(–) VVS (–)
700
600
500
400
300
200
100
0
1234
G Gr ro ou up ps s
c
c
S
S
N
N
R
R
T
T
 
 
v
v
a
a
r
r
i
i
a
a
b
b
i
i
l
l
i
i
t
t
y
y
2400
2200
2000
1800
1600
1400
1200
1000
800
600
400
200
0
1234
G Gr ro ou up ps s
c
c
S
S
N
N
R
R
T
T
 
 
v
v
a
a
r
r
i
i
a
a
b
b
i
i
l
l
i
i
t
t
y
y
 
 
(
(
A
A
B
B
)
)
F Fi ig gu ur re e   2 2. .   Corrected sinus node recovery time (cSNRT) variability in groups 1-4 in the basal state (A A) and after auto-
nomic blockade (B B)
Group 1: SND(+) VVS(+), group 2: SND(+), group 3: VVS (+), group 4: SND(–) VVS (–)
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with cSNRT > 800 ms had an eight times higher risk
of having syncope than patients with cSNRTs below
this value, but there are no more prospective data
on this subject [1]. According to the last ESC Guide-
lines, prolonged cSNRT > 525 is diagnostic and indi-
cates SND as a cause of syncope [2].
In our study, the basal state values of cSNRT in
both groups with SND (1 and 2) were longer than
reported by Alboni et al. [21]. After AB, the values
of cSNRT in group 1 were similar and longer in
group 2 patients than in the study cited above. 
There were no differences between groups 1 and
2 (with and without syncope) with regard to SNRT,
cSNRT and IIP in the basal state. Surprisingly, after
AB all these parameters were significantly longer
in patients without syncope. Abnormal IHR was
found in 50% of patients in group 1 and 54% in
group 2, so the percentage of intrinsic dysfunction
in both groups was the same and cannot be an
explanation for different reaction to AB. It appears
that patients in group 1 had increased vagal stim-
ulation at the basal state, which is in accordance
with the data from heart rate variability analysis in
vasovagal patients [22].
There are other studies which also suggest that
autonomic modulation plays a crucial role in reveal-
ing syncope in patients with SND. Alboni et al. com-
pared two groups of patients with sinus bradycar-
dia less than 50/min [23]. As in our study, cSNRT
was not different in patients with a history of syn-
cope and patients without syncope. Patients with
incidents of syncope had an abnormal IHR more
often (in 66%) and patients without syncope less
often (26%) than in our study. Brignole et al. stud-
ied 35 patients with SND and incidents of syncope
[24]. Fifty-four percent of patients had a positive
result of HUTT and in 80% either HUTT or carotid
sinus massage (CSM) were positive. The results
were independent of the presence of intrinsic SND
or the severity of bradycardia. The authors sug-
gested that an abnormal neural reflex is essential
in the development of syncope in SND. This is also
supported by reports of results of various ablation
procedures on sinus node function in patients treat-
ed for tachyarrhythmias [25, 26] and “cardioneu-
roablation” in patients with reflex syncope, func-
tional atrioventricular block and SND [27]. 
The limitation of the study is that we had no
patients with SND and syncope of different than
vasovagal origin. Therefore, we are not able to con-
firm whether group 1 patients really had concurrent
vasovagal syncope or they just presented the reflex
nature of syncope episodes in SND.
The importance of SACT assessment is still
unclear. The Strauss method was the first to esti-
mate SACT and remains the most widely used. It is
supposed to be more reliable, but it is time-con-
suming and has numerous limitations. The method
by Narula has an advantage of simplicity but the
liabilities are similar to the first method. Based on
our previous experience in transoesophageal pac-
ing, we decided to use both methods of SACT
assessment to avoid too many missing data. 
It has been suggested that the chaotic reaction
of the sinus node (SN) to premature impulses is
typical for SND. Breithardt et al. have interpreted it
as a result of SN automatism and sinoatrial con-
duction disturbances [28]. Sadowski and Szwed
reported chaotic behaviour of sinoatrial conduction
in 8.6% of patients with SND [29]. They proposed
that this chaotic reaction itself indicates SND. 
In our study, patients with SND and suspected
VVS (group 1) had greater SACT St variability than
all other subjects. Additionally, there was no corre-
lation between greater SACT St variability and
a positive HUTT result. Thus, increased SACT St vari-
ability is the phenomenon characterizing coexis-
tence of SND and VVS. We hypothesize that the
main reason for greater SACT variability is the dis-
tinct autonomic modulation of a dysfunctional sinus
node. Schuessler proposed a new model of the SN
based on recent research data [30]. He assumed
that the SN consists of cells with different intrinsic
rates and that there are specialized pathways 
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F Fi ig gu ur re e   3 3. .   Second pause (IIP) variability in groups 1-4 in the basal state (A A) and after autonomic blockade (B B)
Group 1: SND(+) VVS(+), group 2: SND(+), group 3: VVS (+), group 4: SND(–) VVS (–)
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within the node and a limited number of exit sites.
Besides, there is a heterogeneous distribution of
autonomic receptors. Such a complex structure may
cause different disturbances of sinus rhythm, espe-
cially when structural and autonomic changes 
overlap.
However, there are some technical problems con-
cerning the indirect method of SACT assessment,
which is critically dependent on regularity of the
sinus cycle. Further studies in larger study groups
are needed to ascertain that SACT St variability of
sinus rhythm is not just an effect of sinus rhythm
irregularity. 
The basal state variability of SNRT, cSNRT and
IIP in group 1 patients was similar to that in group 2
and significantly greater than the corresponding
values in groups 3 and 4. This may suggest that
increased basal state variability of SNRT, cSNRT and
IIP is typical for SND. The only explanation we have
for greater variability of the above-mentioned
parameters in group 2 is the increased sympathet-
ic modulation of the sinus node before AB. Once
more, an additional group composed of patients
with syncope caused by SND alone would possibly
facilitate the answer.
Clinical, electrographic and electrophysiological
features of SND can be triggered by disturbances
of the autonomic nervous system [7]. They can be
isolated or concomitant to structural damage of
the sinus node. Since Jordan et al.’ study, the terms
“functional” and “intrinsic” dysfunction of sinus
node have been accepted [31]. Assessment of
intrinsic heart rate by pharmacological autonom-
ic blockade has become one of the most widely
used tests of sinus node function. In our study,
pharmacological autonomic blockade was not only
the way to detect an intrinsic dysfunction of the
sinus node. The AB revealed many additional elec-
trophysiological features, especially in patients with
SND and VVS. 
During transoesophageal pacing, among various
properties of sinus node assessed at baseline and
with the use of AB, there is also a possibility to test
the Wenckebach point, which is considered to
reflect atrioventricular (AV) nodal conduction [11].
WP refers to the pacing rate (during incremental
atrial pacing) at which AV nodal Wenckebach (Mob-
itz I) block occurs. In patients with SND the pres-
ence of concomitant atrioventricular node dys-
function is important because it affects therapeutic
decisions (e.g. the type of implanted pacemaker)
[7]. In the present study, patients with SND and VVS
had lower WP than patients with neither SND nor
VVS. In the basal state, abnormal atrioventricular
conduction was more frequent in both groups with
VVS. However, it seems that patients with con-
comitant SND might also have decreased atri-
oventricular node function which persists after
autonomic blockade, indicating organic dysfunc-
tion of the AV node. In contrast, subjects with VVS
and without SND had mostly functional impairment
of AV node conduction, which was due to increased
parasympathetic drive.
In conclusion, patients with concurrent sinus
node dysfunction and vasovagal syncope have dis-
tinct electrophysiological features. This group is
characterized by a greater SACT St variability com-
pared to patients without incidents of syncope.
Apart from abnormal SNRT, cSNRT and IIP, patients
with SND have greater variability of these param-
eters in the basal state. In patients with SND and
concurrent vasovagal syncope the variability of
SNRT, cSNRT and IIP decreases after autonomic
blockade, indicating increased vagal modulation in
the basal state. Transoesophageal atrial pacing is
a useful procedure in patients with syncope, espe-
cially when the coexistence of more than one car-
diac cause is suspected. The protocol after phar-
macological autonomic blockade is an essential part
of the procedure which can reveal different elec-
trophysiological parameters depending on the dis-
tinct aetiology of incidents.
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